Central germline testing confirmed that 388 of the 391 patients had a BRCA1/2 mutation, 1 had a BRCA variant of uncertain significance, and 2 had wild-type BRCA. Testing at Foundation Medicine showed that the 2 patients with wild-type BRCA on central germline testing had somatic BRCA mutations